Interdisziplinäres Zentrum für Klinische Forschung (IZKF)

IZKF-J70 (M4): From gene to function: a translational pipeline for gene discovery and allele testing in kidney disease Oct. 1, 2018 - Sept. 30, 2021 E31: Targeting impaired proteasomal degradation in neurodevelopmental disorders Jan. 1, 2020 - Aug. 31, 2021 IZKF-N1-GA: Understanding the plasticity of cancer cells Aug. 1, 2015 - July 31, 2021 IZKF-J74 (PS): The role of CtBP1 in hippocampal and cortical neuroplasticity Feb. 1, 2019 - July 31, 2021 IZKF-N1 Plasticity of cancer cells: Understanding the plasticity of cancer cells Aug. 1, 2015 - July 31, 2021 ZKF-J67 (M5): Metabolic Reprogramming as a Gatekeeper for Induction/Function of Myeloid Derived Suppressor Cells in AML Jan. 1, 2018 - June 30, 2021 IZKF-J71 (M4): Inhibition of the purinergic receptor P2Y2R as a potential therapeutic intervention in ADPKD Jan. 1, 2019 - June 30, 2021 P065: The homeoprotein transcription factor Engrailed-1 mediates fibroblast activation and skin fibrosis June 29, 2020 - June 28, 2021 P068(Biochemie u.Pathobioch.): Impact of the cellular microenvironment of brain organoids on pericyte-to-neuron direct reprogramming June 1, 2020 - May 31, 2021 IZKF-P060: ERVs in the anti-tumoral immune response via IFN-signaling during development of MIBC June 1, 2020 - May 31, 2021